• EndoStim Inc.

         EndoStim Inc., based in St. Louis, MO, and The Hague, The Netherlands, has developed a laparoscopically implanted stimulation system that delivers electrical impulses to treat gastroesophageal reflux disease. In May, the company secured $25 million in venture funding that will help it conduct a pivotal U.S. clinical trial.Continue >>Don't miss the MD&M Minneapolis conference and expo, September 21–22, 2016.[image courtesy of the company]
  • OptiScan Biomedical Inc.

         OptiScan Biomedical’s OptiScanner 5000 bedside blood monitoring system automates monitoring of patients’ plasma glucose levels in the intensive care unit, and the company is expanding its platform to measure hemoglobin and central venous oxygen saturation levels. Monitoring these metrics can provide early warning when a critically ill patient’s condition goes downhill. The OptiScanner 5000 has been sold in Europe since 2014. OptiScan Biomedical nabbed $29.5 million in...
  • Sonendo Inc.

         Sonendo’s GentleWave System, which uses ultrasonic technology to make root canal procedures easier on patients, was a finalist in the 2016 Medical Design Excellence Awards. The Laguna Hills, CA-based company raked in $33.3 million from venture capitalists in Q2. Continue >>Don't miss the MD&M Minneapolis conference and expo, September 21–22, 2016.[image courtesy of the company]
  • CVRx Inc.

         CVRx says its implantable Barostim System “triggers the body’s own natural blood flow regulation system” to treat high blood pressure and heart failure. The device has the CE Mark and may be sold in Europe but is limited to investigational use in the United States, although it has received Expedited Access Pathway from FDA. The Minneapolis-based company attracted $46.5 million in venture funding this past quarter.Continue >>Don't miss the MD&M Minneapolis...
  • Livongo Health

         Livongo Health’s program for diabetes management combines a connected glucometer with 24/7 support from certified diabetes educators who connect with users via phone, email, text, and mobile app. The Mountain View, CA-based company received a $49.5 million injection of venture capital in Q2. Continue >>Don't miss the MD&M Minneapolis conference and expo, September 21–22, 2016.[image courtesy of the company]
  • TransMedics Inc.

         Transmedics is seeking to improve the process of transferring organs from donors to transplant patients, which typically involves a simple cooler and lots of room for error. The Andover, MA-based company’s Organ Care System provides a better way to maintain organs such as hearts, lungs, and livers outside the body through proprietary perfusion technology. Venture capitalists pumped in $51.2 million last quarter.Continue >>Don't miss the MD&M Minneapolis...
  • Earlens Corp.

         Earlens Corp.’s novel hearing aid uses a processor and light tip to convert sound to light, which is transmitted to a lens inside the ear that stimulates the users own hearing system. The result eliminates the annoying whistling sound that plagues traditional hearing aids. The Menlo Park, CA-based company brought in $53.6 million in venture capital last quarter.Continue >>Don't miss the MD&M Minneapolis conference and expo, September 21–22, 2016.[image...
  • Mitralign Inc.

         Mitralign plays in the hot markets of transcatheter mitral and tricuspid valve repair. Its Mitralign Percutaneous Annuloplasty System (MPAS) received the CE Mark this past February for treatment of functional mitral regurgitation, and its Trialign system for treatment of functional tricuspid regurgitation is now enrolling patients in an early feasibility IDE study in the United States. The $39.8 million the Tewksbury, MA-based company brought in in venture capital last...
  • 10 Medtech Startups on Fire in Q2 2016

        Venture capital investment in medical device and equipment companies rose 3%, to $538.8 million during the second quarter of 2016, according to MoneyTree report from the National Venture Capital Association, PwC, and Thomson Reuters. The number of deals also increased, from 58 in the first quarter of the year to 61 in the second.In particular, the following medical device startups caught investors’ eyes, raising a combined total of more than $371 million in venture capital...
  • SI-Bone Inc.

         Spun out of Wright Medical’s acquisition of INBONE Technologies, San Jose, CA-based SI-Bone developed the iFuse Implant System for treating some causes of sacroiliac joint pain, which received FDA clearance back in 2008. Last quarter, the company raked in $20 million from venture capitalists.Continue >>Don't miss the MD&M Minneapolis conference and expo, September 21–22, 2016.[image courtesy of the company]
  • RefleXion Medical Inc.

         RefleXion Medical is developing a system that will improve radiotherapy for cancer patients by helping to speed positron emission tomography imaging used to guide treatment. The system has not yet been cleared by FDA. The company, which is based in Hayward, CA, raised $23 million in VC funding last quarter.Continue >>Don't miss the MD&M Minneapolis conference and expo, September 21–22, 2016.[image courtesy of the company]
  • 3-D Printer Hack Can Detect Infectious Diseases

    Using repurposed 3-D printer parts, researchers were able to prep samples and amplify DNA at a fraction of the cost associated with traditional equipment.Kristopher SturgisThe latest in 3-D printing technology aims to enable researchers to perform sample preparation and DNA amplification—all done with repurposed 3-D printing components for a fraction of the cost. The new technology was created at AI Biosciences Inc. where Season Wong, company CEO and cofounder, realized that 3-D printers...
  • Eating Disorder Community: New Weight-Loss Device Is ‘Dangerous’

    The Academy for Eating Disorders called the AspireAssist device “truly disturbing” and is asking FDA to revoke its approval.Nancy CrottiUpdated July 29, 2016Qmed readers recently told us  they find Aspire Bariatrics’ recently approved stomach-draining device “scary.” Apparently, the Academy for Eating Disorders agrees.The group’s president plans to submit a letter to FDA asking the agency to revoke its recent approval of the AspireAssist, an obesity treatment device that uses a surgically...
  • Could Matters Get Any Worse for Alere?

    As feds seek info on the company's Medicare, Medicaid, and drug-test billing records, Abbott remains mum on its proposed takeover.Nancy CrottiFederal investigators subpoenaed Alere’s government-billing records last month, potentially driving another wedge into the company’s proposed $6 billion takeover by Abbott Laboratories.Attend the MD&M Minneapolis conference and expo, September 21 & 22, 2016.The news precipitated Alere’s biggest one-day stock plunge ever, a 29% drop to $31.47 at...
  • Top Hospital Embraces Therapeutic Virtual Reality

    A new partnership between Cedars-Sinai Medical Center and AppliedVR will bring virtual reality content to patients in the hospital's orthopedic, spine, and surgery centers.Kristopher SturgisAppliedVR, a leader in virtual reality content, has announced a partnership with Cedars-Sinai Medical Center to introduce therapeutic virtual reality content to patients in the hospital’s spine, orthopedic, and surgery centers.Stay on top of emerging trends in medtech by attending the MD&M Minneapolis...
  • Boston Scientific Beefs Up Neuromodulation Business with Latest Acquisition

    The company has acquired Massachusetts-based Cosman Medical Inc., which makes radiofrequency ablation systems for treatment of chronic pain.Nancy CrottiBoston Scientific is adding to its neuromodulation business with the acquisition of a privately owned radiofrequency ablation company.Don't miss the MD&M Minneapolis conference and expo, September 21 & 22, 2016.The Marlborough, MA, medtech giant has acquired Cosman Medical Inc. in nearby Burlington, MA, for an undisclosed sum....
  • Microneedle Monitors Drug Levels Without Drawing Blood

    A microreactor inside the needle measures drug concentrations in fluid just below the outer layer of skin.Nancy CrottiResearchers have created a microneedle drug monitoringsystem that can collect fluid and analyze the concentrationof a drug in the bloodstream.Researchers may have discovered a way to measure drug levels in blood without actually drawing any blood.Scientists from University of British Columbia and the Paul Scherrer Institut in Switzerland invented a microneedle that can...
  • Edwards Lifesciences's TAVR Sales Soared in Q2

    Sales of Edwards's transcatheter heart valve therapy products grew nearly 50% over the same quarter last year, according to the company's most recent earnings report.Qmed StaffEdwards Lifesciences’s financial performance in the second quarter of 2016 exceeded leadership’s expectations thanks in part to strong sales of the company’s transcatheter heart valve therapy products.Hear from Edwards Lifesciences and other innovators in the structural heart space at the MD&M Minneapolis...
  • Placenta-on-a-Chip Could Help Preemie Babies

    Researchers at the University of Pennsylvania have produced a placenta-on-a-chip, and their study could help determine causes of premature birth.Nancy CrottiEngineers have replicated human lungs, livers, intestines, eyes, and skin on computer chips. Add to that growing list the human placenta.Researchers at the University of Pennsylvania have produced a placenta-on-a-chip that can “fully model the transport of nutrients across the placental barrier,” according to a statement from the university...
  • CMS's New Bundled Payments Plan Could Be a Boon for Medtech

    The agency’s proposal for streamlining high-volume, high-expense episodes of care, including heart attacks, could present opportunities for medical device companies to help hospitals better manage patients.Nancy CrottiThe Obama administration has released a proposal to bundle Medicare payments to hospitals for heart attacks, coronary artery bypass graft procedures, and surgical treatments for broken hips and femurs, excluding joint replacements.Don't miss the MD&M Minneapolis conference and...